1. Home
  2. MDWD vs HITI Comparison

MDWD vs HITI Comparison

Compare MDWD & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • HITI
  • Stock Information
  • Founded
  • MDWD 2000
  • HITI 2009
  • Country
  • MDWD Israel
  • HITI Canada
  • Employees
  • MDWD N/A
  • HITI N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • HITI
  • Sector
  • MDWD Health Care
  • HITI
  • Exchange
  • MDWD Nasdaq
  • HITI Nasdaq
  • Market Cap
  • MDWD 208.2M
  • HITI 187.8M
  • IPO Year
  • MDWD 2014
  • HITI N/A
  • Fundamental
  • Price
  • MDWD $19.34
  • HITI $2.36
  • Analyst Decision
  • MDWD Strong Buy
  • HITI Strong Buy
  • Analyst Count
  • MDWD 2
  • HITI 2
  • Target Price
  • MDWD $35.00
  • HITI $4.75
  • AVG Volume (30 Days)
  • MDWD 48.9K
  • HITI 283.5K
  • Earning Date
  • MDWD 08-13-2025
  • HITI 06-16-2025
  • Dividend Yield
  • MDWD N/A
  • HITI N/A
  • EPS Growth
  • MDWD N/A
  • HITI N/A
  • EPS
  • MDWD N/A
  • HITI N/A
  • Revenue
  • MDWD $19,213,000.00
  • HITI $398,202,371.00
  • Revenue This Year
  • MDWD $20.80
  • HITI $12.43
  • Revenue Next Year
  • MDWD $26.92
  • HITI $11.39
  • P/E Ratio
  • MDWD N/A
  • HITI N/A
  • Revenue Growth
  • MDWD N/A
  • HITI 9.22
  • 52 Week Low
  • MDWD $14.14
  • HITI $1.57
  • 52 Week High
  • MDWD $24.00
  • HITI $3.62
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 40.24
  • HITI 54.32
  • Support Level
  • MDWD $18.97
  • HITI $2.24
  • Resistance Level
  • MDWD $19.87
  • HITI $2.35
  • Average True Range (ATR)
  • MDWD 0.57
  • HITI 0.09
  • MACD
  • MDWD -0.17
  • HITI 0.01
  • Stochastic Oscillator
  • MDWD 25.31
  • HITI 86.27

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

Share on Social Networks: